Diversion ostomy improves treatment tolerance, conversion surgery, and survival compared with self-expanding metal stenting in initially unresectable obstructive colorectal cancer - Report - MDSpire

Diversion ostomy improves treatment tolerance, conversion surgery, and survival compared with self-expanding metal stenting in initially unresectable obstructive colorectal cancer

  • By

  • Fengbin Cai

  • Weiming Jiang

  • Huali Cai

  • Bo Hu

  • July 15, 2026

Share

Clinical Report: Diversion Ostomy Enhances Treatment Tolerance in Colorectal Cancer

Overview

This study demonstrates that diversion ostomy (DO) significantly improves treatment tolerance, surgical conversion rates, and overall survival compared to self-expanding metal stenting (SEMS) in patients with initially non-resectable obstructive colorectal cancer.

Background

Colorectal cancer is a leading cause of cancer-related mortality, with many patients presenting with non-resectable obstructive disease. Effective decompression strategies are crucial for enabling subsequent systemic therapy and potential surgical resection. This study addresses the comparative effectiveness of DO and SEMS, two common decompression methods, in improving clinical outcomes for these patients.

Data Highlights

OutcomeDO GroupSEMS GroupP-value
CROSS score 3 achievement85.5%47.2%<0.001
Median chemotherapy cycles62<0.001
Objective response rate69.4%30.2%<0.001
Subsequent resection rate69.4%30.2%<0.001
Median overall survival27.8 months10.3 months<0.0001

Key Findings

  • DO achieved CROSS score 3 in 85.5% of patients compared to 47.2% for SEMS (P<0.001).
  • Patients in the DO group received a median of 6 chemotherapy cycles, while those in the SEMS group received 2 (P<0.001).
  • Objective response rates were significantly higher in the DO group (69.4%) compared to the SEMS group (30.2%) (P<0.001).
  • The subsequent resection rate was also higher in the DO group at 69.4% versus 30.2% in the SEMS group (P<0.001).
  • Median overall survival was significantly longer in the DO group at 27.8 months compared to 10.3 months in the SEMS group (P<0.0001).

Clinical Implications

The findings indicate differences in outcomes between diversion ostomy and self-expanding metal stenting in patients with obstructive colorectal cancer.

Conclusion

Diversion ostomy is associated with improved clinical outcomes compared to self-expanding metal stenting in patients with initially non-resectable obstructive colorectal cancer.

Related Resources & Content

  1. Updates in Surgery, 2026 -- Comparison analysis of short-term outcomes between degradable stent placement and diverting ileostomy in mid-to-low rectal cancer
  2. Techniques in Coloproctology, 2025 -- Double-tube End Ileostomy: A Viable Alternative to Conventional Defunctioning Stomas in Rectal Surgical Procedures
  3. Journal of Gastrointestinal Surgery, 2022 -- Targeted Application of Diverting Stomas in Rectal Surgical Procedures
  4. Recommendations | Colorectal cancer | Guidance | NICE
  5. A Quarter-Century of Diversion Colitis: Understanding the Condition's Evolution
  6. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial
  7. Short‐term and long‐term outcomes of self‐expandable metallic stent placement versus creation of a diverting stoma for obstructive colorectal cancer: A systematic review and meta‐analysis
  8. Recommendations | Colorectal cancer | Guidance | NICE

Original Source(s)

Related Content